Reviewer #2 (Public Review):
Summary:<br /> The manuscript by Kelbert et al. presents results on the involvement of the yeast transcription factor Sfp1 in the stabilisation of transcripts whose synthesis it stimulates. Sfp1 is known to affect the synthesis of a number of important cellular transcripts, such as many of those that code for ribosomal proteins. The hypothesis that a transcription factor can remain bound to the nascent transcript and affect its cytoplasmic half-life is attractive, but the methods used to demonstrate the half-life effects and the association of Sfp1 with cytoplasmic transcripts remain to be fully validated, as explained in my comments on the results below:
Comments on methodology and results:<br /> (1) A two-hybrid-based assay for protein-protein interactions identified Sfp1, a transcription factor known for its effects on ribosomal protein gene expression, as interacting with Rpb4, a subunit of RNA polymerase II. Classical two-hybrid experiments depend on the presence of the tested proteins in the nucleus of yeast cells, suggesting that the observed interaction occurs in the nucleus. Unfortunately, the two-hybrid method cannot determine whether the interaction is direct or mediated by nucleic acids.
(2) Inactivation of nup49, a component of the nuclear pore complex, resulted in the redistribution of GFP-Sfp1 into the cytoplasm at the temperature non-permissive for the nup49-313 strain, suggesting that GFP-Sfp1 is a nucleo-cytoplasmic shuttling protein. This observation confirmed the dynamic nature of the nucleo-cytoplasmic distribution of Sfp1. For example, a similar redistribution to the cytoplasm was previously reported following rapamycin treatment and under starvation (Marion et al., PNAS 2004). In conjunction with the observation of an interaction with Rpb4, the authors observed slower nuclear import kinetics for GFP-Sfp1 in the absence of Rpb4 when cells were transferred to a glucose-containing medium after a period of starvation. Since the redistribution of GFP-Sfp1 was abolished in an rpb1-1/nup49-313 double mutant, the authors concluded that Sfp1 localisation to the cytoplasm depends on transcription. The double mutant yeast cells may show a variety of non-specific effects at the restrictive temperature, and whether transcription is required for Sfp1 cytoplasmic localisation remains incompletely demonstrated.
(3) Under starvation conditions, which led to the presence of Sfp1 in the cytoplasm and have previously been correlated with a decrease in the transcription of Sfp1 target genes, the authors observed that a plasmid-based expressed GFP-Sfp1 accumulated in cytoplasmic foci. These foci were also labelled by P-body markers such as Dcp2 and Lsm1. The quality of the microscopic images provided does not allow to determine whether Rpb4-RFP colocalises with GFP-Sfp1.
(4) To understand to which RNA Sfp1 might bind, the authors used an N-terminally tagged fusion protein in a cross-linking and purification experiment. This method identified 264 transcripts for which the CRAC signal was considered positive and which mostly correspond to abundant mRNAs, including 74 ribosomal protein mRNAs or metabolic enzyme-abundant mRNAs such as PGK1. The authors did not provide evidence for the specificity of the observed CRAC signal, in particular, what would be the background of a similar experiment performed without UV cross-linking. In a validation experiment, the presence of several mRNAs in a purified SFP1 fraction was measured at levels that reflect the relative levels of RNA in a total RNA extract. Negative controls showing that abundant mRNAs not found in the CRAC experiment were clearly depleted from the purified fraction with Sfp1 would be crucial to assessing the specificity of the observed protein-RNA interactions. The CRAC-selected mRNAs were enriched for genes whose expression was previously shown to be upregulated upon Sfp1 overexpression (Albert et al., 2019). The presence of unspliced RPL30 pre-mRNA in the Sfp1 purification was interpreted as a sign of co-transcriptional assembly of Sfp1 into mRNA, but in the absence of valid negative controls, this hypothesis would require further experimental validation.
(5) To address the important question of whether co-transcriptional assembly of Spf1 with transcripts could alter their stability, the authors first used a reporter system in which the RPL30 transcription unit is transferred to vectors under different transcriptional contexts, as previously described by the Choder laboratory (Bregman et al. 2011). While RPL30 expressed under an ACT1 promoter was barely detectable, the highest levels of RNA were observed in the context of the native upstream RPL30 sequence when Rap1 binding sites were also present. Sfp1 showed better association with reporter mRNAs containing Rap1 binding sites in the promoter region. However, removal of the Rap1 binding sites from the reporter vector also led to a drastic decrease in reporter mRNA levels. Whether the fraction of co-purified RNA is nuclear and co-transcriptional or not cannot be inferred from these results.
(6) To complement the biochemical data presented in the first part of the manuscript, the authors turned to the deletion or rapid depletion of SFP1 and used labelling experiments to assess changes in the rate of synthesis, abundance, and decay of mRNAs under these conditions. An important observation was that in the absence of Sfp1, mRNAs encoding ribosomal protein genes not only had a reduced synthesis rate but also an increased degradation rate. This important observation needs careful validation, as genomic run-on experiments were used to measure half-lives, and this particular method was found to give results that correlated poorly with other measures of half-life in yeast (e.g. Chappelboim et al., 2022 for a comparison). Similarly, the use of thiolutin to block transcription as a method of assessing mRNA half-life has been reported to be problematic, as thiolutin can specifically inhibit the degradation of ribosomal protein mRNA (Pelechano & Perez-Ortin, 2008). Specific repressible reporters, such as those used by Baudrimont et al. (2017), would need to be tested to validate the effect of Sfp1 on the half-life of specific mRNAs. Also, it would be very difficult to infer from the images presented whether the rate of deadenylation is altered by Sfp1.
(7) The effects of SFP1 on transcription were investigated by chromatin purification with Rpb3, a subunit of RNA polymerase, and the results were compared with synthesis rates determined by genomic run-on experiments. The decrease in polII presence on transcripts in the absence of SFP1 was not accompanied by a marked decrease in transcript output, suggesting an effect of Sfp1 in ensuring robust transcription and avoiding RNA polymerase backtracking. To further investigate the phenotypes associated with the depletion or absence of Sfp1, the authors examined the presence of Rpb4 along transcription units compared to Rpb3. One effect of spf1 deficiency was that this ratio, which decreased from the start of transcription towards the end of transcripts, increased slightly. The results presented are largely correlative and could arise from the focus on very specific types of mRNAs, such as those of ribosomal protein genes, which are sensitive to stress and are targeted by very active RNA degradation mechanisms activated, for example, under heat stress (Bresson et al., 2020).
Strengths:<br /> - Diversity of experimental approaches used<br /> - Validation of large-scale results with appropriate reporters
Weaknesses:<br /> - Choice of evaluation method to test mRNA half-life<br /> - Lack of controls for the CRAC results